2014
DOI: 10.1007/s12190-014-0803-4
|View full text |Cite
|
Sign up to set email alerts
|

Global stability analysis of HIV-1 infection model with three time delays

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0
5

Year Published

2016
2016
2020
2020

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 25 publications
(21 citation statements)
references
References 57 publications
0
16
0
5
Order By: Relevance
“…Following [2,4,6,10], we introduce the set of assumptions that determine dynamics of HIV-1 infection:…”
Section: Moreover Let S Denotes the Cell Source In Bone Marrow And Lmentioning
confidence: 99%
See 1 more Smart Citation
“…Following [2,4,6,10], we introduce the set of assumptions that determine dynamics of HIV-1 infection:…”
Section: Moreover Let S Denotes the Cell Source In Bone Marrow And Lmentioning
confidence: 99%
“…Mostly, these models are divided into deterministic and stochastic one. Deterministic models take the form of the systems of delay differential equations [3,4]. The equations of such models describe concentration of target cells, infected cells, viral particles, etc.…”
Section: Introductionmentioning
confidence: 99%
“…To understand how models are currently used to represent the progression of this disease, we considered 40 recent models of within-host dynamics, all of which are expressed as nonlinear systems of differential equations. Of these models, one used stochastic differential equations Wang, Liu, Xu & Zhang (2015) and eight used delayed differential equations (Huang et al (2016) , Alshorman et al (2016), Pitchaimani & Monica (2015), Sahani (2016), Balasubramaniam et al (2015), Elaiw & Almuallem (2016)). In addition, the focus of several of these papers was somewhat different from ours.…”
Section: Of 32mentioning
confidence: 99%
“…In Ref. [13], the authors considered the therapy of reverse transcriptase inhibitors (RTIs) drugs which have different drug efficacy on CD4+ T cells, to block conversion of uninfected cells to infected cells. In Refs [14,15], protease inhibitor (PI) drugs therapy was designed to intervene replication of the virus, make the newly produced virus noninfectious.…”
Section: Introductionmentioning
confidence: 99%